Validation of the Severe-Respiratory-Insufficiency Questionnaire (SRI) for COPD patients receiving long-term oxygen therapy

Validation of the Severe-Respiratory-Insufficiency Questionnaire (SRI) for COPD patients receiving long-term oxygen therapy - HRQL LTOT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00006067

Enrollment

130

Registered

2014-04-28

Start date

2009-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44.81 J96.10 J96.11

Interventions

Group 1: Health-related quality of life as assessed by the SRI questionnaire in COPD patients with long-term oxygen therapy Group 2: Health-related quality of life as assessed by the SRI questionnaire

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: COPD patients with established (at least 1 month) NIV or LTOT-therapy, respectively.

Exclusion criteria

Exclusion criteria: LTOT and/or NIV as treatment of other chronic pulmonary or ventialtory diseases Exacerbations within the last 4 weeks Malignancies Language comprehension disorders

Design outcomes

Primary

Measure	Time frame
Primary endpoint is the assessment of reliability of the SRI questionnaire for the LTOT group using the cronbach's alpha.	—

Secondary

Measure	Time frame
Secondary endpoints are differences in the SRI sum scale or subscales between the LTOT and NIV groups.	—

Countries

Germany

Contacts

Public ContactWolfram Windisch

Universitätsklinik Freiburg Abt. Pneumologie

wolfram.windisch@uniklinik-freiburg.de076127037310

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026